Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
出版年份 2019 全文链接
标题
Efficacy and Safety of Dual Blockade of the Renin–Angiotensin–Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis
作者
关键词
-
出版物
American Journal of Cardiovascular Drugs
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-02-09
DOI
10.1007/s40256-018-00321-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Additive Therapy With Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy
- (2016) Mohammad G. Saklayen et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial
- (2015) Sawako Kato et al. Clinical and Experimental Nephrology
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
- (2015) Suetonia C Palmer et al. LANCET
- Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy
- (2014) P. N. Van Buren et al. Clinical Journal of the American Society of Nephrology
- Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes
- (2014) Rajesh Garg et al. DIABETES
- Efficacy and Safety of Combined vs. Single Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease: A Meta-Analysis
- (2013) P. Susantitaphong et al. AMERICAN JOURNAL OF HYPERTENSION
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Effects of dual blockade of the renin–angiotensin system on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy and hypertension in the ORIENT: a post-hoc analysis (ORIENT–Hypertension)
- (2013) Enyu Imai et al. HYPERTENSION RESEARCH
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
- (2013) Linda F. Fried et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Dual Blockade of the Renin-Angiotensin System on the Progression of Type 2 Diabetic Nephropathy: A Randomized Trial
- (2012) Gema Fernandez Juarez et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study
- (2012) S. E. Nielsen et al. DIABETIC MEDICINE
- Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus
- (2012) George L. Bakris et al. Journal of Clinical Hypertension
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes
- (2012) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy
- (2012) Akihiko Nakamura et al. Journal of Diabetes Investigation
- ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial
- (2011) S.M. Titan et al. CLINICAL NEPHROLOGY
- Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy
- (2011) Frederik Persson et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Of fads, fashion, surrogate endpoints and dual RAS blockade
- (2010) F. H. Messerli et al. EUROPEAN HEART JOURNAL
- Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination
- (2009) A. S. Bomback et al. AMERICAN JOURNAL OF HYPERTENSION
- Managing diabetes in hemodialysis patients: Observations and recommendations
- (2009) K. SHRISHRIMAL et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Cystatin C, Albuminuria, and Mortality Among Older Adults With Diabetes
- (2009) I. H. de Boer et al. DIABETES CARE
- Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria
- (2009) F. Persson et al. DIABETES CARE
- Global estimates of the prevalence of diabetes for 2010 and 2030
- (2009) J.E. Shaw et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Valsartan in combination with lisinopril versus the respective high dose monotherapies in hypertensive patients with microalbuminuria: the VALERIA trial
- (2009) Jan Menne et al. JOURNAL OF HYPERTENSION
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
- (2009) U. F. Mehdi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The current state of RAAS blockade in the treatment of hypertension and proteinuria
- (2009) Rigas G. Kalaitzidis et al. Current Cardiology Reports
- Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
- (2008) Fausta Catapano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Is There Added Value to Adding ARB to ACE Inhibitors in the Management of CKD?
- (2008) D. L. Cohen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started